CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Medistim ASA Company Snapshot
Medistim ASA operates in the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medistim ASA with three other medical equipment manufacturers in Europe: Pulsion Medical Systems Aktiengesellschaft of Germany (2017 sales of 25.56 million Euro [US$29.18 million] of which 100% was Critical Care), Cellavision AB of Sweden (309.31 million Swedish Kronor [US$33.91 million] of which 100% was Automatic Microscopy), and Revenio Group Oyj which is based in Finland (26.79 million Euro [US$30.58 million] ).

Sales Analysis. Medistim ASA reported sales of NOK 301.46 million (US$36.04 million) for the year ending December of 2017. This represents an increase of 12.5% versus 2016, when the company's sales were NOK 268.06 million. Sales at Medistim ASA have increased during each of the previous five years (and since 2012, sales have increased a total of 64%). Sales of Capital Sales saw an increase of 15.2% in 2017, from NOK 108.62 million to NOK 125.18 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Medistim ASA
  Stock Performance Chart for Medistim ASA
 
  Stock Data: Recent Stock Performance:
  Current Price (8/10/2018): 80.40
(Figures in Norwegian Kroner)
1 Week -0.7%   13 Weeks -0.7%  
4 Weeks 1.3%   52 Weeks 5.8%  
 
Medistim ASA Key Data:
  Ticker: MEDI Country: Norway
  Exchanges: OSL Major Industry: Health Care Equipment & Services
    Sub Industry: Electromedical Equipment
  2017 Sales 301,461,000
(Year Ending Jan 2018).
Employees: 103
  Currency: Norwegian Kroner Market Cap: 1,503,707,130
  Fiscal Yr Ends: December Shares Outstanding: 18,702,825
  Share Type: Ordinaere Aksje Closely Held Shares: 5,844,590
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.